Document is current
Any future updates will be listed below
-
Authors
Schoretsanitis, Georgios https://orcid.org/0000-0002-3851-4117
Osborne, Lauren M. https://orcid.org/0000-0003-0979-7901
Sundström-Poromaa, Inger https://orcid.org/0000-0002-2491-2042
Wenzel, Elizabeth S.
Payne, Jennifer L. https://orcid.org/0000-0003-0006-1199
Barbui, Corrado https://orcid.org/0000-0003-1073-9282
Gastaldon, Chiara
Deligiannidis, Kristina M. https://orcid.org/0000-0001-7439-2236
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K23MH110607, R01MH120313, K23MH097794)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- License Information
-
More Information
Article History
Received: 24 April 2024
Revised: 30 August 2024
Accepted: 3 September 2024
First Online: 7 November 2024
Competing interests
: KMD serves as a consultant to Sage Therapeutics, Brii Biosciences, Gerbera Therapeutics, GH Research, Neuroscience Software and Reunion Neuroscience. KMD served as a study principal investigator for contracted research awarded to the Feinstein Institutes for Medical Research from Sage Therapeutics, Woebot Health and Premier Healthcare. JLP receives research support from NIMH and Janssen Pharmaceuticals. JLP has two patents: “Epigenetic Biomarkers of Postpartum Depression” and “Epigenetic Biomarkers of Premenstrual Dysphoric Disorder and SSRI Response.” JLP has Founder’s Stock options in Dionysus Health. JLP has received consulting fees from SAGE Therapeutics, Biogen, Flo Health, Pure Tech, Brii Biosciences, and Merck. She receives royalties from UpToDate and Elsevier. She has produced content for and received honoraria from CMEToGo, Peerview Institute for Medical Education, Global Learning Collaborative, and Karuna Therapeutics. Georgios Schoretsanitis has served as a consultant for Dexcel Pharma, HLS Therapeutics and Thermo Fisher and has received speaker fees from HLS Therapeutics and Saladax. All other authors declare no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. No informed consent was necessary for this type of research.
